促红细胞生成素通过增加神经氨酸酶3表达诱导去唾液酸化促进类风湿关节炎进展
研究检测了类风湿关节炎(RA)患者血清和滑液中促红细胞生成素(EPO)水平,发现EPO在RA患者中过表达且与疾病活动度评分DAS28正相关;在胶原诱导性关节炎(CIA)小鼠中,EPO干预可显著加重关节破坏。机制上,EPO通过其受体EPOR激活JAK2-STAT5信号通路上调神经氨酸酶3(NEU3)表达,促进成纤维样滑膜细胞去唾液酸化,增强其迁移和侵袭能力。
要点
- RA患者血清和滑液中EPO过表达,且与DAS28评分正相关。
- EPO干预可显著加重CIA模型小鼠的关节破坏。
- EPO通过EPOR激活JAK2/STAT5通路上调NEU3,促进FLS迁移和侵袭。
核心结论
- EPO作为促炎因子,通过JAK2/STAT5通路转录上调NEU3表达,加速RA进程。
研究设计与样本
- 检测RA患者与健康对照血清和滑液中EPO水平;构建CIA小鼠确认EPO在RA发病中的作用;对EPO处理的成纤维样滑膜细胞(FLS)进行转录组测序筛选差异表达基因;通过双荧光素酶报告实验、DNA下拉、电泳迁移率变动分析和染色质免疫沉淀-定量PCR验证NEU3的转录因子。
主要发现
- EPO在RA患者中过表达,且与DAS28评分正相关。
- EPO干预可显著加重CIA模型的关节破坏。
- EPO处理的FLS中NEU3表达上调,经转录组测序和qPCR验证。
- 信号转导与转录激活因子5(STAT5)被筛选并验证为NEU3的特异性转录因子。
- EPO通过其受体EPOR激活JAK2-STAT5信号通路上调NEU3表达,促进FLS迁移和侵袭能力,该效应经JAK2抑制剂和NEU3抑制剂验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Erythropoietin (EPO) known as an erythrocyte-stimulating factor is increased in patients with rheumatoid arthritis (RA). Nevertheless, the function of EPO in the process of RA and relative mechanism needs to be further clarified. METHODS: The level of EPO in serum and synovial fluid from patients with RA and healthy controls was determined by . Collagen-induced arthritis (CIA) mice were constructed to confirm the role of EPO on RA pathogenesis. Differentially expressed genes (DEGs) of EPO-treated fibroblast-like synoviocyte (FLS) were screened by transcriptome sequencing. The transcription factor of neuraminidase 3 (NEU3) of DEGs was verified by double luciferase reporting experiment, DNA pulldown, electrophoretic mobility shift assay and chromatin immunoprecipitation-quantitative PCR (qPCR) assay. RESULTS: The overexpression of EPO was confirmed in patients with RA, which was positively associated with Disease Activity Score 28-joint count. Additionally, EPO intervention could significantly aggravate the joint destruction in CIA models. The upregulation of NEU3 was screened and verified by transcriptome sequencing and qPCR in EPO-treated FLS, and signal transducer and activator of transcription 5 was screened and verified to be the specific transcription factor of NEU3. EPO upregulates NEU3 expression via activating the Janus kinase 2 (JAK2)-STAT5 signalling pathway through its receptor EPOR, thereby to promote the desialylation through enhancing the migration and invasion ability of FLS, which is verified by JAK2 inhibitor and NEU3 inhibitor. CONCLUSION: EPO, as a proinflammatory factor, accelerates the process of RA through transcriptional upregulation of the expression of NEU3 by JAK2/STAT5 pathway.
引用
- Wu G, Cao B, Zhai H, et al. EPO promotes the progression of rheumatoid arthritis by inducing desialylation via increasing the expression of neuraminidase 3. Ann Rheum Dis. 2024. PMID: 38272667. doi:10.1136/ard-2023-224852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。